Press Release

Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Touchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesJim Faulkner, Nicole Mather and Carolyn Porter join the Cell and Gene Therapy Catapult as Non-Executive DirectorsJim Faulkner, Nicole Mather and Carolyn Porter join the Cell and Gene Therapy Catapult as Non-Executive Directors£17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK: NIHR, Innovate UK and CGT Catapult align strategically to further improve patient access and the UK’s leadership£17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK: NIHR, Innovate UK and CGT Catapult align strategically to further improve patient access and the UK’s leadershipBraintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapiesBraintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapiesEducation Secretary joins Cell and Gene Therapy Catapult to celebrate apprenticesEducation Secretary joins Cell and Gene Therapy Catapult to celebrate apprenticesUK maintains its position as an attractive destination for advanced therapy clinical trialsUK maintains its position as an attractive destination for advanced therapy clinical trialsCell and Gene Therapy Catapult announces successful renewal of its five-year funding from Innovate UK to further support the advanced therapies sectorCell and Gene Therapy Catapult announces successful renewal of its five-year funding from Innovate UK to further support the advanced therapies sectorLeading industry surveys demonstrate continued growth in the UK’s cell and gene therapy sectorLeading industry surveys demonstrate continued growth in the UK’s cell and gene therapy sectorCell and Gene Therapy Catapult focuses on strategic areas to further unlock the full potential of the UK advanced therapy industryCell and Gene Therapy Catapult focuses on strategic areas to further unlock the full potential of the UK advanced therapy industryCryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene TherapiesCryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene TherapiesCell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandCell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapies